EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild‐Type Receptors: Identification of Highly Selective Inhibitors That Block the Process

Haijiang Wang, Xinxin Liu, Gido Gravesteijn, Alessia Atella, Jin Liu, Julie W Rutten, Peter Ten Dijke, Manuel A F V Gonçalves, Saskia A J Lesnik Oberstein, David A Baker iD

The FASEB Journal · 31.03.2026 · 40 (6)

DOI: 10.1096/fj.202504022r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 10.03.2026. Verfasst von Haijiang Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Receptor, Notch3, CADASIL. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding (KWF), Oncode Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral autosomal dominant arteriopathy with subcortical infarctions and leukoencephalopathy (CADASIL) is a monogenic autosomal dominant small vessel disease clinically characterized by a broad spectrum of symptoms including recurrent ischemic strokes, cognitive dysfunction, and premature dementia. It is caused (predominantly) by cysteine‐altering mutations in exons encoding the epidermal growth factor‐like repeats (EGFrs) of the extracellular domain of the NOTCH3 receptor, which are associated with pathological impairment of the cerebral vasculature. Whilst the pathophysiological features of the condition are well established, the precise molecular mechanisms by which NOTCH3 mutations trigger the disease have remained unclear. In this study, we have biochemically interrogated the impact of different pathogenic NOTCH3 CADASIL variants on NOTCH3 receptor aggregation (and signaling) using novel in vitro analyses and cell‐based assays. By these means, we found that CADASIL mutant receptors alone could not self‐associate into high molecular mass assemblies, but did promote NOTCH receptor aggregation only in combination with wild‐type receptors. Moreover, pathogenic CADASIL variants localized to the EGFr 4 of NOTCH3 specifically and significantly enhanced JAGGED1 (JAG1)‐dependent NOTCH3 transactivation. Importantly, we show that unique, paralogue‐specific NOTCH3 inhibitors can block both receptor aggregation and CADASIL mutant gain‐of‐function NOTCH3 signaling, which could represent a new therapeutic approach to treating the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Notch3CADASILHumansMutationSignal TransductionAnimalsHEK293 Cells

Stichwörter der Autor:innen

CADASILNOTCH receptor inhibitorsNOTCH signalingpeptide‐based inhibitorsprotein aggregationtargeted therapy

Substanzen

Receptor, Notch3NOTCH3 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
  • Department of Cell & Chemical Biology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
  • Department of Clinical Genetics, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
  • Oncode Institute and Department of Cell & Chemical Biology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.

ORCID-Profile: David A Baker

Förderung

  • KWF Kankerbestrijding (KWF)
  • Oncode Institute

Zitieren

APA

Wang, H., Liu, X., Gravesteijn, G., Atella, A., Liu, J., Rutten, J. W., Ten Dijke, P., Gonçalves, M. A. F. V., Lesnik Oberstein, S. A. J., & Baker, D. A. (2026). NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild‐Type Receptors: Identification of Highly Selective Inhibitors That Block the Process. The FASEB Journal, 40(6). https://doi.org/10.1096/fj.202504022r

Vancouver

Wang H, Liu X, Gravesteijn G, Atella A, Liu J, Rutten JW, et al. NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild‐Type Receptors: Identification of Highly Selective Inhibitors That Block the Process. The FASEB Journal. 2026;40(6). doi:10.1096/fj.202504022r

BibTeX
@article{Wang2026,
  author = {Wang, Haijiang and Liu, Xinxin and Gravesteijn, Gido and Atella, Alessia and Liu, Jin and Rutten, Julie W and Ten Dijke, Peter and Gonçalves, Manuel A F V and Lesnik Oberstein, Saskia A J and Baker, David A},
  title = {NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild‐Type Receptors: Identification of Highly Selective Inhibitors That Block the Process},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {6},
  doi = {10.1096/fj.202504022r}
}
Kostenlos starten →